|
Type of medicine: Medicines containing chemical active substances
|
|
Therapeutic area: Behavior and Behavior Mechanisms [F01]
|
| Brands: Please see report, Please see report, Please see report |
| MAH holders: Please see report, Please see report, Please see report, Please see report |
| Assessment: |
| Active substance: FLUOXETINE |
| ATC code: |
| Document link:
fluoxetine B1Y-MC-HCCJ Clinical Study Summary.pdf
|
|
Document date: 2011-09-23
|
| Study number: B1Y-MC-HCCJ |
|
EudraCT number:
|
| Scope of study: Clinical |
|
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
|
-
|
-
|
-
|
-
|
Y
|